NIDDK Awards ASU's Biodesign Institute $3.1M to Validate Diabetes Protein Markers | GenomeWeb

This story originally ran on May. 6.

By Adam Bonislawski

A team of researchers at Arizona State University's Biodesign Institute has won a $3.1 million award from the National Institute of Diabetes and Digestive and Kidney Diseases to identify and validate protein biomarkers associated with the development of type 2 diabetes and heart disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.